Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis

Journal of Neuroimmunology

Volumn 216, Issue 1-2, 2009, Pages 98-102

  Berg Hansen, Pål ^a   Vandvik, Bodvar ^a   Fagerhol, Magne ^a   Holmøy, Trygve ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Biomarkers; Calprotectin; Cerebrospinal fluid; Multiple sclerosis

Indexed keywords

CALGRANULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 71749085981     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.09.006     Document Type: Article

References (25)

1. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004) 458-468
2. Beschorner R., Nguyen T.D., Gozalan F., Pedal I., Mattern R., Schluesener H.J., Meyermann R., and Schwab J.M. CD14 expression by activated parenchymal microglia/macrophages and infiltrating mocytes following human traumatic brain injury. Acta Neuropathol. 6 (2002) 541-549
3. Bogumil T., Rieckmann P., Kubuschok B., Felgenhauer K., Bruck W., et al. Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis. Neurosci. Lett. 247 2-3 (1998) 195-197
4. Breij E.C., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., and Bo L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 63 (2008) 16-25
5. Bruck W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H.A., and Lassmann H. Mocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38 (1995) 788-796
6. Cepok S., Jacobsen M., Schock S., Omer B., Jaekel S., Boddeker I., Oertel W.H., Sommer N., and Hemmer B. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124 (2001) 2169-2176
7. Corbin B.D., Seeley E.H., Raab A., Feldmann J., Miller M.R., Torres V.J., Anderson K.L., Dattilo B.M., Dunman P.M., Gerads R., Caprioli R.M., Nacken W., Chazin W.J., and Skaar E.P. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319 (2008) 962-965
8. Dale I., Fagerhol M.K., and Naesgaard I. Purification and partial characterization of a highly immugenic human leukocyte protein, the L1 antigen. Eur. J. Biochem. 134 (1983) 1-6
9. Dunlop O., Bruun J.N., Myrvang B., and Fagerhol M.K. Calprotectin in cerebrospinal fluid of the HIV infected: a diagnostic marker of opportunistic central nervous system infection?. Scand. J. Infect. Dis. 23 (1991) 687-689
10. Fagerhol M.K. Calprotectin, a faecal marker of organic gastrointestinal abrmality. Lancet 356 (2000) 1783-1784
11. Floris S., van der G.A., Killestein J., Kl D.L., Barkhof F., Polman C.H., Dijkstra C.D., de Vries H.E., and Meilof J.F. Mocyte activation and disease activity in multiple sclerosis. A longitudinal analysis of serum MRP8/14 levels. J. Neuroimmunol. 148 (2004) 172-177
12. Foster R., Kandanearatchi A., Beasley C., Williams B., Khan N., Fagerhol M.K., and Everall I.P. Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process?. Eur. J. Neurosci. 24 (2006) 3561-3566
13. Frosch M., Strey A., Vogl T., Wulffraat N.M., Kuis W., Sunderkotter C., Harms E., Sorg C., and Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43 (2000) 628-637
14. Giovanni G. Multiple sclerosis cerebrospinal fluid biomarkers. Dis. Markers 22 (2006) 187-196
15. Golden B.E., Clohessy P.A., Russell G., and Fagerhol M.K. Calprotectin as a marker of inflammation in cystic fibrosis. Arch. Dis. Child. 74 (1996) 136-139
16. Johne B., Fagerhol M.K., Lyberg T., Prydz H., Brandtzaeg P., Naess-Andresen C.F., and Dale I. Functional and clinical aspects of the myelomocyte protein calprotectin. Mol. Pathol.. 50 (1997) 113-123
17. Madland T.M., Hordvik M., Haga H.J., Jonsson R., and Brun J.G. Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study. Scand. J. Rheumatol. 31 (2002) 351-354
18. Martin R., Bielekova B., Hohlfeld R., and Utz U. Biomarkers in multiple sclerosis. Dis. Markers 22 (2006) 183-185
19. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
20. Prineas J.W., and Wright R.G. Macrophages lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38 (1978) 409-421
21. Sander J., Fagerhol M.K., Bakken J.S., and Dale I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand. J. Clin. Lab. Invest. 44 (1984) 357-362
22. Schumacher G.A., Beebe G., Kibler R.F., Kurkand L.T., Kurtzke J.F., McDowell F., Nagler B., Sibley W.A., Tourtellotte W.W., and Willmon T.L. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of the therapy in multiple sclerosis. Ann. N. Y. Acad. Sci. 122 (1965) 552-568
23. Tumani H., Teunissen C., Sussmuth S., Otto M., Ludolph A.C., and Brettschneider J. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. Expert Rev. Mol. Diagn. 8 (2008) 479-494
24. Vogl T., Ludwig S., Goebeler M., Strey A., Thorey I.S., Reichelt R., Foell D., Gerke V., Manitz M.P., Nacken W., Werner S., Sorg C., and Roth J. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 104 (2004) 4260-4268
25. Weiss N., Miller F., Cazaubon S., and Couraud P.O. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta 1788 (2009) 842-857